DENTSPLY SIRONA (XRAY) investor relations material

Leadership and organizational transformation

• Executive team strengthened with new talent and board members, including expertise in banking and dental distribution.

• Lean and Agile methodologies implemented to drive customer focus and operational speed.

• Resource reallocation prioritized toward customer-facing roles, with back-office streamlining to fund sales force expansion.

• Integration of previously acquired businesses underway to centralize support and enhance efficiency.

• Commitment to a 24-month turnaround plan, maintaining urgency and aiming for stabilization and growth.

Strategic initiatives in core business segments

• Dealer network selectively expanded in the U.S. and Canada to increase equipment penetration.

• Verticalization of sales force by clinical specialty and investment in clinical education to accelerate market penetration.

• Focus on revitalizing CEREC and DS Core integration to drive single-visit dentistry adoption.

• R&D investment to support both evolutionary and disruptive innovation, with increased spend expected next year.

• Digital workflow enhancements targeted for both equipment and implant segments.

Implant and orthodontics business outlook

• Expansion of value implant sales force and DSO channel underway, with investments continuing through 2027 and beyond.

• Focus on high-density geographies for value implants, with Europe ahead of the U.S. in execution.

• Ortho business (SureSmile) under strategic review; current focus on specialists and hybrid treatments, with potential for further investment or divestiture.

• Robotic bent wires and software modernization seen as key differentiators in ortho.